Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 3Head & Neck 2Gynecologic 2Sarcoma 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 1423Uterine Cervical Neoplasms 926Endometrial Neoplasms 493Carcinoma, Ovarian Epithelial 426Breast Neoplasms 425Fallopian Tube Neoplasms 413Neoplasms 274Uterine Cervical Dysplasia 208Colorectal Neoplasms 170Carcinoma, Non-Small-Cell Lung 168Pancreatic Neoplasms 156Prostatic Neoplasms 153Lung Neoplasms 151Stomach Neoplasms 126Peritoneal Neoplasms 119Sarcoma 117Uterine Neoplasms 112Melanoma 111Urinary Bladder Neoplasms 108Papillomavirus Infections 107Colonic Neoplasms 106Head and Neck Neoplasms 105Vulvar Neoplasms 101Esophageal Neoplasms 100Recurrence 95Testicular Neoplasms 91Carcinoma, Renal Cell 89Vaginal Neoplasms 79Small Cell Lung Carcinoma 77Kidney Neoplasms 74

Interventions

Isotretinoin 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × AIDS-Related Complex × Gynecologic × Clear all
NCT00000758 2021-11-04

A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 3 Completed
158 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Uterine Cervical Diseases, Uterine Cervical Dysplasia, HIV Infections

NCT00001073 2021-11-04

Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 3 Completed
150 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Uterine Cervical Diseases, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡